Fresenius Medical Care AG & Co. KGaA (FMS) Stock Forecast, Price Target & Predictions
FMS Stock Forecast
Fresenius Medical Care AG & Co. KGaA stock forecast is as follows: an average price target of $17.85 (represents a -15.36% downside from FMS’s last price of $21.09) and a rating consensus of 'Hold', based on 1 wall street analysts offering a 1-year stock forecast.
FMS Price Target
The average price target for Fresenius Medical Care AG & Co. KGaA (FMS) is $17.85 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $24.00 to $11.70. This represents a potential -15.36% downside from FMS's last price of $21.09.
FMS Analyst Ratings
According to 1 Wall Street analysts, Fresenius Medical Care AG & Co. KGaA's rating consensus is 'Hold'. The analyst rating breakdown for FMS stock is 0 'Strong Buy' (0.00%), 0 'Buy' (0.00%), 1 'Hold' (100.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Fresenius Medical Care AG & Co. KGaA Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 15, 2024 | David MacDonald | Truist Financial | $24.00 | $22.48 | 6.79% | 13.80% |
| Jan 02, 2023 | James Vane-Tempest | Jefferies | $11.70 | $16.34 | -28.40% | -44.52% |
| Jun 22, 2022 | - | Truist Financial | $27.00 | $23.64 | 14.24% | 28.02% |
The latest Fresenius Medical Care AG & Co. KGaA stock forecast, released on May 15, 2024 by David MacDonald from Truist Financial, set a price target of $24.00, which represents a 6.79% increase from the stock price at the time of the forecast ($22.48), and a 13.80% increase from FMS last price ($21.09).
Fresenius Medical Care AG & Co. KGaA Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 1 |
| Avg Price Target | - | - | $24.00 |
| Last Closing Price | $21.09 | $21.09 | $21.09 |
| Upside/Downside | -100.00% | -100.00% | 13.80% |
In the current month, the average price target of Fresenius Medical Care AG & Co. KGaA stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Fresenius Medical Care AG & Co. KGaA's last price of $21.09. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jul 31, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
| May 13, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
| Jan 02, 2023 | Jefferies | - | Underperform | Downgrade |
Fresenius Medical Care AG & Co. KGaA's last stock rating was published by Barclays on Jul 31, 2024. The company gave FMS a "Equal-Weight" rating, the same as its previous rate.
Fresenius Medical Care AG & Co. KGaA Financial Forecast
Fresenius Medical Care AG & Co. KGaA Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | $4.70B | $5.00B | $5.10B | $4.76B | $4.55B | $4.65B | $4.44B | $4.32B | $4.21B | $4.40B | $4.41B | $4.56B | $4.49B | $4.58B | $4.42B | $4.35B | $4.13B | $4.30B | $4.06B |
| Avg Forecast | $4.29B | $6.44B | $6.44B | $4.29B | $6.18B | $5.49B | $5.44B | $4.93B | $5.36B | $5.20B | $5.30B | $5.14B | $5.30B | $4.88B | $4.77B | $4.84B | $5.21B | $5.30B | $5.21B | $5.18B | $5.60B | $5.34B | $5.23B | $4.84B | $5.00B | $4.87B | $4.85B | $4.58B | $3.88B | $4.42B |
| High Forecast | $4.36B | $6.54B | $6.54B | $4.36B | $6.28B | $5.56B | $5.52B | $5.01B | $5.53B | $5.29B | $5.39B | $5.22B | $5.39B | $4.95B | $4.77B | $4.91B | $5.28B | $5.37B | $5.28B | $5.26B | $5.68B | $5.42B | $5.31B | $4.91B | $5.07B | $4.94B | $4.92B | $4.65B | $4.65B | $5.30B |
| Low Forecast | $4.22B | $6.33B | $6.33B | $4.22B | $6.08B | $5.44B | $5.35B | $4.85B | $5.12B | $5.12B | $5.21B | $5.05B | $5.21B | $4.80B | $4.77B | $4.77B | $5.13B | $5.22B | $5.13B | $5.11B | $5.51B | $5.26B | $5.16B | $4.77B | $4.93B | $4.80B | $4.78B | $4.52B | $3.10B | $3.54B |
| # Analysts | - | - | - | - | 1 | 2 | 1 | 1 | 3 | 1 | - | - | - | - | - | - | - | - | - | 11 | 11 | 9 | 8 | 8 | 7 | 5 | 5 | 5 | 13 | 15 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.92% | 0.94% | 1.05% | 1.00% | 0.94% | 0.89% | 0.84% | 0.83% | 0.81% | 0.79% | 0.83% | 0.87% | 0.93% | 0.92% | 0.91% | 0.90% | 0.90% | 1.11% | 0.92% |
Fresenius Medical Care AG & Co. KGaA's average Quarter revenue forecast for Jun 23 based on 0 analysts is $5.30B, with a low forecast of $5.21B, and a high forecast of $5.39B. FMS's average Quarter revenue forecast represents a 12.70% increase compared to the company's last Quarter revenue of $4.70B (Mar 23).
Fresenius Medical Care AG & Co. KGaA EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | 1 | 2 | 1 | 1 | 3 | 1 | - | - | - | - | - | - | - | - | - | 11 | 11 | 9 | 8 | 8 | 7 | 5 | 5 | 5 | 13 | 15 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | $720.01M | $377.00M | $989.68M | $776.01M | $780.74M | $839.62M | $864.89M | $773.04M | $822.32M | $996.35M | $966.09M | $1.00B | $896.92M | $1.00B | $966.46M | $847.40M | $869.86M | $854.01M | $651.55M |
| Avg Forecast | $539.64M | $809.46M | $809.46M | $539.64M | $777.66M | $691.04M | $683.63M | $644.46M | $674.47M | $654.49M | $666.79M | $585.88M | $666.77M | $933.76M | $599.73M | $532.61M | $394.94M | $848.88M | $848.32M | $651.76M | $996.35M | $858.75M | $869.18M | $1.09B | $924.12M | $880.17M | $899.28M | $797.37M | $770.01M | $709.72M |
| High Forecast | $548.46M | $822.70M | $822.70M | $548.46M | $790.38M | $698.74M | $694.80M | $773.36M | $696.03M | $665.19M | $677.69M | $703.05M | $677.67M | $1.12B | $599.73M | $639.14M | $473.93M | $1.02B | $1.02B | $661.15M | $1.20B | $1.03B | $1.04B | $1.31B | $1.11B | $1.06B | $1.08B | $956.85M | $924.01M | $851.67M |
| Low Forecast | $530.82M | $796.23M | $796.23M | $530.82M | $764.95M | $684.61M | $672.45M | $515.57M | $644.05M | $643.78M | $655.88M | $468.70M | $655.86M | $747.01M | $599.73M | $426.09M | $315.95M | $679.10M | $678.66M | $642.37M | $797.08M | $687.00M | $695.34M | $873.00M | $739.29M | $704.13M | $719.43M | $637.90M | $616.01M | $567.78M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 1.23% | 0.57% | 1.06% | 1.29% | 1.47% | 2.13% | 1.02% | 0.91% | 1.26% | 1.00% | 1.13% | 1.15% | 0.82% | 1.09% | 1.10% | 0.94% | 1.09% | 1.11% | 0.92% |
0 analysts predict FMS's average Quarter EBITDA for Jun 23 to be $666.79M, with a high of $677.69M and a low of $655.88M. This is -7.39% lower than Fresenius Medical Care AG & Co. KGaA's previous annual EBITDA (Mar 23) of $720.01M.
Fresenius Medical Care AG & Co. KGaA Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | 1 | 2 | 1 | 1 | 3 | 1 | - | - | - | - | - | - | - | - | - | 11 | 11 | 9 | 8 | 8 | 7 | 5 | 5 | 5 | 13 | 15 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | $133.85M | $194.00M | $230.10M | $206.00M | $211.81M | $303.74M | $273.04M | $218.58M | $248.95M | $177.18M | $353.50M | $350.97M | $282.72M | $342.51M | $332.58M | $253.78M | $270.75M | $424.77M | $284.61M |
| Avg Forecast | - | - | - | - | $144.49M | $114.65M | $108.80M | $139.63M | $128.27M | $84.38M | $84.65M | $126.94M | $89.70M | $294.79M | $235.87M | $115.40M | $224.42M | $267.99M | $240.01M | $139.30M | $177.18M | $314.22M | $304.62M | $343.97M | $315.32M | $302.89M | $269.32M | $248.19M | $382.99M | $310.03M |
| High Forecast | - | - | - | - | $147.56M | $117.08M | $111.11M | $167.56M | $135.40M | $86.17M | $86.45M | $152.33M | $91.60M | $353.74M | $235.87M | $138.48M | $269.30M | $321.59M | $288.01M | $141.91M | $212.62M | $377.07M | $365.54M | $412.77M | $378.39M | $363.47M | $323.18M | $297.82M | $459.59M | $372.03M |
| Low Forecast | - | - | - | - | $141.41M | $111.92M | $106.49M | $111.71M | $121.15M | $82.59M | $82.85M | $101.55M | $87.79M | $235.83M | $235.87M | $92.32M | $179.54M | $214.39M | $192.00M | $136.69M | $141.75M | $251.38M | $243.69M | $275.18M | $252.26M | $242.31M | $215.45M | $198.55M | $306.39M | $248.02M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 1.05% | 2.16% | 0.78% | 0.87% | 1.84% | 1.35% | 1.02% | 0.91% | 1.79% | 1.00% | 1.13% | 1.15% | 0.82% | 1.09% | 1.10% | 0.94% | 1.09% | 1.11% | 0.92% |
Fresenius Medical Care AG & Co. KGaA's average Quarter net income forecast for Jun 23 is $84.65M, with a range of $82.85M to $86.45M. FMS's average Quarter net income forecast represents a -36.76% decrease compared to the company's last Quarter net income of $133.85M (Mar 23).
Fresenius Medical Care AG & Co. KGaA SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | 1 | 2 | 1 | 1 | 3 | 1 | - | - | - | - | - | - | - | - | - | 11 | 11 | 9 | 8 | 8 | 7 | 5 | 5 | 5 | 13 | 15 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | $782.15M | $955.00M | $989.61M | $969.49M | $871.24M | $823.21M | $731.23M | $830.18M | $711.51M | $879.37M | $717.75M | $738.08M | $854.46M | $831.40M | $724.43M | $802.53M | $715.16M | $729.05M | $742.68M |
| Avg Forecast | $761.53M | $1.14B | $1.14B | $761.53M | $1.10B | $975.18M | $964.72M | $773.08M | $951.80M | $923.60M | $940.96M | $702.80M | $940.93M | $789.46M | $846.32M | $638.91M | $806.54M | $717.69M | $911.57M | $919.75M | $879.37M | $638.00M | $640.60M | $1.04B | $765.41M | $659.75M | $851.66M | $655.56M | $657.34M | $808.99M |
| High Forecast | $773.98M | $1.16B | $1.16B | $773.98M | $1.12B | $986.05M | $980.49M | $927.70M | $982.22M | $938.70M | $956.34M | $843.36M | $956.31M | $947.35M | $846.32M | $766.69M | $967.85M | $861.23M | $1.09B | $933.01M | $1.06B | $765.60M | $768.71M | $1.25B | $918.50M | $791.70M | $1.02B | $786.67M | $788.80M | $970.79M |
| Low Forecast | $749.08M | $1.12B | $1.12B | $749.08M | $1.08B | $966.12M | $948.95M | $618.46M | $908.87M | $908.50M | $925.57M | $562.24M | $925.54M | $631.57M | $846.32M | $511.13M | $645.23M | $574.15M | $729.25M | $906.50M | $703.49M | $510.40M | $512.48M | $831.68M | $612.33M | $527.80M | $681.33M | $524.45M | $525.87M | $647.19M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 1.11% | 1.01% | 1.25% | 1.15% | 1.36% | 1.02% | 1.02% | 0.91% | 0.77% | 1.00% | 1.13% | 1.15% | 0.82% | 1.09% | 1.10% | 0.94% | 1.09% | 1.11% | 0.92% |
Fresenius Medical Care AG & Co. KGaA's average Quarter SG&A projection for Jun 23 is $940.96M, based on 0 Wall Street analysts, with a range of $925.57M to $956.34M. The forecast indicates a 20.30% rise compared to FMS last annual SG&A of $782.15M (Mar 23).
Fresenius Medical Care AG & Co. KGaA EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | 1 | 2 | 1 | 1 | 3 | 1 | - | - | - | - | - | - | - | - | - | 11 | 11 | 9 | 8 | 8 | 7 | 5 | 5 | 5 | 13 | 15 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | $0.23 | $0.33 | $0.39 | $0.35 | $0.36 | $0.52 | $0.47 | $0.38 | $0.42 | $0.30 | $0.60 | $0.60 | $0.47 | $0.57 | $0.55 | $0.42 | $0.44 | $0.69 | $0.47 |
| Avg Forecast | - | - | - | - | $0.49 | $0.39 | $0.37 | $0.28 | $0.44 | $0.29 | $0.29 | $0.24 | $0.31 | $0.35 | $0.40 | $0.36 | $0.50 | $0.55 | $0.47 | $0.47 | $0.74 | $0.67 | $0.62 | $0.48 | $0.65 | $0.61 | $0.55 | $0.53 | $0.46 | $0.52 |
| High Forecast | - | - | - | - | $0.50 | $0.40 | $0.38 | $0.29 | $0.46 | $0.29 | $0.29 | $0.25 | $0.31 | $0.36 | $0.40 | $0.36 | $0.51 | $0.56 | $0.48 | $0.48 | $0.75 | $0.69 | $0.63 | $0.49 | $0.66 | $0.62 | $0.56 | $0.54 | $0.55 | $0.63 |
| Low Forecast | - | - | - | - | $0.48 | $0.38 | $0.36 | $0.28 | $0.41 | $0.28 | $0.28 | $0.24 | $0.30 | $0.34 | $0.40 | $0.35 | $0.49 | $0.54 | $0.46 | $0.47 | $0.72 | $0.66 | $0.61 | $0.47 | $0.63 | $0.60 | $0.54 | $0.52 | $0.37 | $0.42 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.95% | 1.08% | 1.12% | 0.87% | 1.01% | 1.04% | 0.84% | 0.79% | 0.90% | 0.41% | 0.90% | 0.97% | 0.98% | 0.88% | 0.90% | 0.76% | 0.83% | 1.50% | 0.89% |
According to 0 Wall Street analysts, Fresenius Medical Care AG & Co. KGaA's projected average Quarter EPS for Jun 23 is $0.29, with a low estimate of $0.28 and a high estimate of $0.29. This represents a 25.43% increase compared to FMS previous annual EPS of $0.23 (Mar 23).
Fresenius Medical Care AG & Co. KGaA Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| SGRY | Surgery Partners | $31.00 | $47.50 | 53.23% | Buy |
| SEM | Select Medical | $35.23 | $40.00 | 13.54% | Buy |
| INNV | InnovAge | $5.99 | $6.80 | 13.52% | Hold |
| ACHC | Acadia Healthcare Company | $78.23 | $84.89 | 8.51% | Buy |
| EHC | Encompass Health | $93.25 | $93.17 | -0.09% | Buy |
| ADUS | Addus HomeCare | $130.13 | $123.00 | -5.48% | Buy |
| UHS | Universal Health Services | $232.56 | $208.47 | -10.36% | Hold |
| PNTG | Pennant Group | $34.52 | $30.67 | -11.15% | Buy |
| FMS | Fresenius Medical Care AG & Co. KGaA | $21.09 | $17.85 | -15.36% | Hold |
| THC | Tenet Healthcare | $162.41 | $124.87 | -23.11% | Buy |
| ENSG | Ensign Group | $152.73 | $114.25 | -25.19% | Buy |
| HCA | HCA Healthcare | $394.68 | $291.95 | -26.03% | Buy |
FMS Forecast FAQ
Is Fresenius Medical Care AG & Co. KGaA a good buy?
No, according to 1 Wall Street analysts, Fresenius Medical Care AG & Co. KGaA (FMS) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 0 'Buy' recommendations, accounting for 0% of FMS's total ratings.
What is FMS's price target?
Fresenius Medical Care AG & Co. KGaA (FMS) average price target is $17.85 with a range of $11.7 to $24, implying a -15.36% from its last price of $21.09. The data is based on 1 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Fresenius Medical Care AG & Co. KGaA stock go up soon?
According to Wall Street analysts' prediction for FMS stock, the company can go down by -15.36% (from the last price of $21.09 to the average price target of $17.85), up by 13.80% based on the highest stock price target, and down by -44.52% based on the lowest stock price target.
Can Fresenius Medical Care AG & Co. KGaA stock reach $30?
FMS's average twelve months analyst stock price target of $17.85 does not support the claim that Fresenius Medical Care AG & Co. KGaA can reach $30 in the near future.
What are Fresenius Medical Care AG & Co. KGaA's analysts' financial forecasts?
Fresenius Medical Care AG & Co. KGaA's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $22.04B (high $22.37B, low $21.72B), average EBITDA is $2.8B (high $2.96B, low $2.64B), average net income is $507.57M (high $543.31M, low $471.52M), average SG&A $3.81B (high $4.01B, low $3.61B), and average EPS is $1.54 (high $1.57, low $1.5). FMS's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $21.45B (high $21.8B, low $21.1B), average EBITDA is $2.7B (high $2.74B, low $2.65B), average net income is $0 (high $0, low $0), average SG&A $3.81B (high $3.87B, low $3.75B), and average EPS is $0 (high $0, low $0).
Did the FMS's actual financial results beat the analysts' financial forecasts?
Based on Fresenius Medical Care AG & Co. KGaA's last annual report (Dec 2022), the company's revenue was $19.4B, which missed the average analysts forecast of $19.78B by -1.94%. Apple's EBITDA was $1.58B, missing the average prediction of $2.73B by -42.19%. The company's net income was $673M, missing the average estimation of $735.75M by -8.53%. Apple's SG&A was $3.78B, beating the average forecast of $3.22B by 17.68%. Lastly, the company's EPS was $1.15, missing the average prediction of $1.41 by -18.63%. In terms of the last quarterly report (Mar 2023), Fresenius Medical Care AG & Co. KGaA's revenue was $4.7B, missing the average analysts' forecast of $5.14B by -8.42%. The company's EBITDA was $720.01M, beating the average prediction of $585.88M by 22.89%. Fresenius Medical Care AG & Co. KGaA's net income was $133.85M, beating the average estimation of $126.94M by 5.45%. The company's SG&A was $782.15M, beating the average forecast of $702.8M by 11.29%. Lastly, the company's EPS was $0.23, missing the average prediction of $0.242 by -5.14%